JWH 250 N-<wbr/>(4-<wbr/>hydroxypentyl) metabolite-<wbr/>d<sub>5</sub>

JWH 250 N-(4-hydroxypentyl) metabolite-d5

CAT N°: 11749

JWH 250 N-(4-hydroxypentyl) metabolite-d5 is intended for use as an internal standard for the quantification of JWH 250 N-(4-hydroxypentyl) metabolite (Item No. 10939) by GC- or LC-mass spectrometry. JWH 250 is a synthetic cannabinoid (CB) which potently activates both CB1 and CB2 receptors (Ki = 11 and 33 nM, respectively).{17655} It has been identified in herbal blends.{19508} JWH 250 N-(4-hydroxypentyl) metabolite (Item No. 10939) is expected to be a cytochrome P450 phase I metabolite of JWH 250, detectable both in serum and urine.{19353,18292,18291}

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • 1-(1-(4-hydroxypentyl)-1H-indol-3-yl-2,4,5,6,7-d5)-2-(2-methoxyethanone
  • Correlated keywords
    • JWHs JWH-250 JWH250 metabolites cannabinoids CB1 CB2 CBs herbal smoke smoking forensics receptors agonist cannabimimetic metabolite metabolism deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS analytical references standards
  • Product Overview:
    JWH 250 N-(4-hydroxypentyl) metabolite-d5 is intended for use as an internal standard for the quantification of JWH 250 N-(4-hydroxypentyl) metabolite (Item No. 10939) by GC- or LC-mass spectrometry. JWH 250 is a synthetic cannabinoid (CB) which potently activates both CB1 and CB2 receptors (Ki = 11 and 33 nM, respectively).{17655} It has been identified in herbal blends.{19508} JWH 250 N-(4-hydroxypentyl) metabolite (Item No. 10939) is expected to be a cytochrome P450 phase I metabolite of JWH 250, detectable both in serum and urine.{19353,18292,18291}

We also advise you